Ani Pharmaceuticals (ANIP) Market Capitalization (2013 - 2026)

Ani Pharmaceuticals has disclosed Market Capitalization across 14 years of filings, most recently posting $2.0 billion for Q2 2026.

• In Q2 2026, Market Capitalization rose 35.57% year-over-year to $2.0 billion; the TTM figure through Jun 2026 stood at $2.0 billion (up 35.57% YoY), while the FY2025 annual figure was $1.8 billion, up 52.16% from the prior year.
• Market Capitalization came in at $2.0 billion for Q2 2026 at Ani Pharmaceuticals, up from $1.8 billion in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $2.1 billion in Q3 2025 to a low of $486.3 million in Q1 2022.
• Average Market Capitalization over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2023.
• Year-over-year, Market Capitalization soared 113.2% in 2023 and gained 0.84% in 2025.
• Over 5 years, Market Capitalization stood at $704.0 million in 2022, then jumped by 62.37% to $1.1 billion in 2023, then gained by 2.08% to $1.2 billion in 2024, then soared by 52.16% to $1.8 billion in 2025, then grew by 11.21% to $2.0 billion in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $2.0 billion in Q2 2026, $1.8 billion in Q1 2026, and $1.8 billion in Q4 2025.